VRXA
Veraxa Biotech AG
1.10$
-5.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q2 25 | Q4 25 |
|---|---|---|---|
| 100.0% | 100.0% | 100.0% | |
| 6.6% | 4.7% | 3.6% | |
| 6.3% | 4.0% | 2.0% | |
| 27.0% | 27.8% | 28.3% | |
| 63.1% | 64.1% | 64.2% | |
| 63.4% | 84.5% | 119.5% | |
| 3.0% | 4.0% | 8.2% | |
| 0.6% | 1.4% | 1.7% | |
| 36.6% | 15.5% | -19.5% | |
| -37.6% | -83.3% | -121.8% | |
| 166.8% | 171.9% | 175.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.